This might be the most inspiring cancer survivor story you will ever read
You will survive
A striking woman in her early 40s, Ivelisse lights up a room. She’s one of those passionate people who is just full of life.
At least she is today.
You see, Ivelisse was essentially on the brink of death less than a decade ago, when her doctor first said the word, “cancer.”
She was diagnosed with advanced colon cancer when she was in her late 30s. As a wife and a mother of four, she had at least five great reasons to fight her disease with all her might.
But her situation was desperate. Her chance of survival was less than 10 percent.
Then, just five weeks after a brutal colon surgery, her doctor stunned her with the news that cancer had spread to her liver. Again, she went under the knife to remove the tumor.
But now, the chance that chemotherapy would help her survive was very low. So she opted for an alternative medicine protocol instead. This included mistletoe and thymus injections, along with various supplements.
No chemo. No radiation.
Four years later, Ivelisse is alive. She’s thriving. And she’s cancer-free.
What’s more, she doesn’t have to worry about secondary cancers that chemo and radiation often cause.
Ivelisse’s remarkable experience launched another mission. She and her husband established “Believe Big” — an organization that offers guidance for cancer patients and their families.
They also promote alternative medicine. But this is far more than just a recommendation. They’ve actually begun work on a mistletoe clinical trial with Johns Hopkins Hospital.
If you or someone you care about has cancer, you can take advantage of Believe Big resources immediately by going to their website — believebig.org.
While there, you can read more about Ivelisse’s story and the Johns Hopkins research. And you can even contribute to help fund the study.
I firmly believe that grassroots ventures like this are revolutionizing cancer care. And if that causes drug company executives to turn red with rage, well, then that’s the price we’ll have to pay.


